Hepatocellular carcinoma (HCC)
Conditions
Interventions
Portal vein and/or hepatic vein without compression group:None
Portal vein and/or hepatic vein compression group:None
Sponsors
The Second Affiliated Hospital of Kunming Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) The first clinical diagnosis or the pathological diagnosis by liver biopsy is HCC,Barcelona Clinic Liver Cancer Stage 0-A; (2) Received radical surgical treatment for HCC; (3) Have not received local therapy such as transcatheter arterial chemoembolization (TACE), transcatheter arterial embolization (TAE), transcatheter arterial infusion (TAI), hepatic artery infusion chemotherapy (HAIC) or systemic therapy such as targeted therapy, immunotherapy; (4) Three-stage enhanced CT and MRI scans of the liver were performed 2 weeks before surgery.
Exclusion criteria
Exclusion criteria: (1) Patients combined with life-threatening heart diseases, brain diseases, kidney diseases, or other liver diseases (such as Budd-Chiari syndrome); (2) Patients combined with HIV infection; (3) Missing of CT and MRI data; (4) Missing of clinical data and survival data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival rate;Tumor-free Survival Rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| The maximum diameter of tumor;Number of tumors;Bile duct invasion;The levels of tumor markers;Lymphatic metastasis;Tumor compression;liver function indicators;Microvascular invasion; | — |
Countries
China
Contacts
Public ContactYang Ke
The Second Affiliated Hospital of Kunming Medical University
Outcome results
None listed